Taking oral phosphodiesterase type 5 inhibitors to treat erectile dysfunction and impotency may increase sexual activity but it cannot give satisfaction.

"It is important that health professionals act on this and offer a more rounded approach to managing ED," said Dr. David Lee, lead author of the study from the University of Manchester in Britain. This should include a well-informed patient with realistic expectations, support from his partner, and an improved assessment of any psychological or relationship issues that may exacerbate sexual concerns and dissatisfaction, Lee pointed out.
The researchers studied the responses of more than 2,600 English men aged 50-87 years. Older men who had recently used PDE5i drugs reported higher levels of sexual activity and function than men without ED, but were more likely to be concerned and/or dissatisfied with their sex lives.
The study was published in the International Journal of Impotence Research.
Source-IANS